In summary, our data suggest that reduced levels of SRC-2 in breast cancer cells modulates the expression of estrogen-regulated genes leading to enhanced proliferation of breast cancer cells, suggesting that SRC-2 has antiproliferative properties in breast cancer cells. This evidence concerns the gene NCOA2 and breast cancer.